TKO Group Holdings, Inc. (TKO)

Intra-Cellular Therapies Revenue

TKO Group had revenue of $1.31B in the quarter ending June 30, 2025, with 9.66% growth. This brings the company's revenue in the last twelve months to $2.97B, down -14.74% year-over-year. In the year 2024, TKO Group had annual revenue of $2.80B with 67.43% growth.

• Revenue (ttm): $2.97B
• Revenue Growth: -14.74%
• P/S Ratio: 4.48
• Revenue / Employee: $2,281,495
• Employees: 1,300
• Market Cap: 32.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.80B	1.13B	67.43%
Dec 31, 2023	1.67B	534.82M	46.91%
Dec 31, 2022	1.14B	108.20M	10.49%
Dec 31, 2021	1.03B	140.79M	15.80%
Dec 31, 2020	891.15M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.